Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21243355 | 0.81 | ALDH1A1 (0.40) | ALDH1A1MEN1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21243344 | 0.81 | ALDH1A1 (0.40) | ALDH1A1MEN1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13762649 | 0.80 | ALDH1A1 (0.41) | ALDH1A1MEN1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21243352 | 0.79 | TP53 (0.49) | LMNAHCRTR2 | |
| SCHEMBL21243373 | 0.79 | TLR4 (0.39) | ALDH1A1MEN1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21243375 | 0.78 | TRPM8 (0.41) | LMNAHCRTR2 | |
| SCHEMBL6559290 | 0.78 | HCRTR2 (0.38) | ALDH1A1LMNAHCRTR2 | |
| SCHEMBL21243360 | 0.78 | LMNA (0.49) | ALDH1A1MEN1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11880271 | 0.78 | HCRTR2 (0.38) | ALDH1A1LMNAHCRTR2 | |
| SCHEMBL11882934 | 0.78 | HCRTR2 (0.38) | ALDH1A1LMNAHCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2021-03-16 | — | — | US | disclosed |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | DNAH12, DYNC1LI1, DYNC1LI2 | ALDH1A1 1661/4885MEN1 2513/4885CYP1A2 3601/4885 |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | DNAH12, DYNC1LI1, DYNC1LI2 | ALDH1A1 1661/4885MEN1 2513/4885CYP1A2 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.